Skip to main content

Table 2 Univariate analysis of postoperative morbidity and severe morbidity

From: Analysis of risk factors for postoperative complications in non-small cell lung cancer: comparison with the Japanese National Clinical Database risk calculator

Variables

 

Morbidity

P value

Severe morbidity

P value

  

Absent, n (%)

Present, n (%)

 

Absent, n (%)

Present, n (%)

 

Sex

Man

254 (69.8)

110 (30.2)

0.92

317 (87.1)

47 (12.9)

0.15

 

Woman

155 (70.1)

66 (29.8)

 

201 (90.9)

20 (9.1)

 

Age

 ≥ 75

105 (74.5)

36 (25.5)

0.17

127 (90.1)

14 (9.9)

0.51

 

 < 75

304 (68.5)

140 (31.5)

 

391 (88.1)

53 (11.9)

 

Comorbidity

       

Malignant disease

Absent

347 (68.8)

157 (31.2)

0.16

444 (88.1)

60 (11.9)

0.39

 

Present

62 (76.5)

19 (23.5)

 

74 (91.4)

7 (8.6)

 

Angina pectoris

Absent

386 (70.4)

162 (29.6)

0.28

484 (88.3)

64 (11.7)

0.50

 

Present

23 (62.2)

14 (37.8)

 

34 (91.9)

3 (8.1)

 

Cerebral infarction

Absent

392 (69.9)

169 (30.1)

0.92

495 (88.2)

66 (11.8)

0.25

 

Present

17 (70.8)

7 (29.2)

 

23 (95.8)

1 (4.2)

 

Interstitial lung disease

Absent

402 (69.8)

174 (30.2)

0.60

511 (88.7)

65 (11.3)

0.30

 

Present

7 (77.8)

2 (22.2)

 

7 (77.8)

2 (22.2)

 

Chronic renal failure

Absent

406 (70.2)

172 (29.8)

0.11

512 (88.6)

66 (11.4)

0.81

 

Present

3 (42.8)

4 (57.2)

 

6 (85.7)

1 (14.3)

 

Diabetes mellitus

Absent

355 (70.4)

149 (29.6)

0.49

446 (88.5)

58 (11.5)

0.91

 

Present

54 (66.7)

27 (33.3)

 

72 (88.9)

9 (11.1)

 

COPD

Absent

390 (70.9)

160 (29.1)

0.03

490 (89.1)

60 (10.9)

0.10

 

Present

19 (54.3)

16 (45.7)

 

28 (80.0)

7 (20.0)

 

Asthma

Absent

401 (71.0)

164 (29.0)

 < 0.01

501 (88.7)

64 (11.3)

0.61

 

Present

8 (40.0)

12 (60.0)

 

17 (85.0)

3 (15.0)

 

Arrhythmia

Absent

395 (69.9)

170 (30.1)

0.99

500 (88.5)

65 (11.5)

0.83

 

Present

14 (70.0)

6 (30.0)

 

18 (90.0)

2 (10.0)

 

Autoimmune disease

Absent

397 (69.6)

173 (30.3)

0.38

505 (88.6)

65 (11.4)

0.81

 

Present

12 (80.0)

3 (20.0)

 

13 (86.7)

2 (13.3)

 

Hypertension

Absent

344 (69.8)

149 (30.2)

0.86

433 (87.8)

60 (12.2)

0.20

 

Present

65 (70.6)

27 (29.3)

 

85 (92.4)

7 (7.6)

 

Smoking status

Brinkman index < 600

223 (76.9)

67 (23.1)

 < 0.01

263 (90.7)

27 (9.3)

0.10

 

Brinkman index ≥ 600

186 (63.1)

109 (36.9)

 

255 (86.4)

40 (13.6)

 

BMI

 < 21.88

149 (67.1)

73 (32.9)

0.24

203 (91.4)

19 (8.6)

0.08

 

 ≥ 21.88

260 (71.6)

103 (28.4)

 

315 (86.8)

48 (13.2)

 

CEA

 ≤ 5

299 (72.6)

113 (27.4)

0.03

367 (89.1)

45 (10.9)

0.53

 

 > 5

110 (63.6)

63 (36.4)

 

151 (87.3)

22 (12.7)

 

PNI

 ≥ 49.68

228 (73.3)

83 (26.7)

0.05

282 (90.7)

29 (9.3)

0.08

 

 < 49.68

181 (66.1)

93 (33.9)

 

236 (86.1)

38 (13.9)

 

NLR

 ≤ 1.56

108 (78.3)

30 (20.0)

0.01

124 (89.9)

14 (10.1)

0.58

 

 > 1.56

301 (67.3)

146 (32.7)

 

394 (88.1)

53 (11.9)

 

%VC

 ≥ 80

402 (70.3)

170 (29.7)

0.20

510 (89.2)

62 (10.8)

 < 0.01

 

 < 80

7 (53.8)

6 (46.2)

 

8 (61.5)

5 (38.5)

 

FEV1%

 ≥ 70

285 (75.4)

93 (24.6)

 < 0.01

341 (90.2)

37 (8.6)

0.08

 

 < 70

124 (59.9)

83 (40.1)

 

177 (85.5)

30 (14.5)

 

Pulmonary lobe of NSCLC

RUL

120 (67.0)

59 (33.0)

0.01

157 (87.7)

22 (12.3)

0.16

 

RML

31 (83.8)

6 (16.2)

 

34 (91.9)

3 (8.1)

 
 

RLL

97 (70.8)

40 (29.2)

 

122 (89.1)

15 (10.9)

 
 

LUL

87 (62.6)

52 (37.4)

 

117 (84.2)

22 (15.8)

 
 

LLL

74 (79.6)

19 (20.4)

 

88 (94.6)

5 (5.4)

 
 

RUL or RLL or LUL

304 (66.8)

151 (33.2)

 < 0.01

396 (87.0)

59 (13.0)

0.03

 

RML or LLL

105 (80.8)

25 (19.2)

 

122 (93.9)

8 (6.1)

 

Histological type

Non-Squamous cell carcinoma

343 (71.9)

134 (28.1)

0.02

432 (90.6)

45 (9.4)

 < 0.01

 

Squamous cell carcinoma

66 (61.1)

42 (38.9)

 

86 (79.6)

22 (20.4)

 

Operative approach

VATS or RATS

362 (69.6)

158 (30.4)

0.65

464 (89.2)

56 (10.8)

0.14

 

Open thoracotomy

47 (72.3)

18 (27.7)

 

54 (83.1)

12 (16.9)

 

Operative procedure

Except for segmentectomy

356 (68.9)

161 (31.1)

0.12

452 (87.4)

65 (12.6)

0.01

 

Segmentectomy

53 (77.9)

15 (22.1)

 

66 (97.1)

2 (2.9)

 
 

Except for lobectomy

78 (69.6)

34 (30.4)

0.94

97 (86.6)

15 (13.4)

0.47

 

Lobectomy

331 (70.0)

142 (30.0)

 

421 (89.0)

52 (11.0)

 
 

Except for extend-lobectomy

396 (70.8)

163 (29.2)

0.02

499 (89.3)

60 (10.7)

0.01

 

Extend-lobectomy

13 (50.0)

13 (50.0)

 

19 (73.1)

7 (26.9)

 
 

Except for pneumonectomy

397 (70.0)

170 (30.0)

0.76

506 (89.2)

61 (10.8)

 < 0.01

 

Pneumonectomy

12 (66.7)

6 (33.3)

 

12 (66.7)

6 (33.3)

 
  1. COPD chronic obstructive pulmonary disease, BMI body mass index, CEA carcinoembryonic antigen, PNI prognostic nutritional index, NLR neutrophil-to-lymphocyte ratio, VC vital capacity, FEV1% forced expiratory volume % in one second, NSCLC non-small cell lung cancer, RUL right upper lobe, RML right middle lobe, RLL right lower lobe, LUL left upper lobe, LLL left lower lobe, PNI prognostic nutritional index, NLR neutrophil-to-lymphocyte ratio, VATS video-assisted thoracic surgery, RATS robotic-assisted thoracic surgery